SCHEMBL5562883

SCHEMBL5562883

CC(C)C1Oc2ccc(Br)cc2C(OC(=O)NC(C)(C)C)N(Cc2ccc(N(C)C)cc2)C1=O

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
LMNA P02545 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
THRB P10828 1/20 0.31
PKM P14618 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HDAC1 Q13547 2/20 0.30
HDAC6 Q9UBN7 2/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556744 0.86 KCNA5 (0.32) ITGB2ICAM1ITGALALDH1A1MAPT
SCHEMBL5556226 0.78 LMNA (0.41) ITGB2ICAM1ITGALALDH1A1MAPT
SCHEMBL5555513 0.78 LRRK2 (0.35) ITGB2ICAM1ITGALALDH1A1MAPT
SCHEMBL5560808 0.76 KCNA5 (0.37) ALDH1A1MAPTLMNANPSR1TDP1
SCHEMBL5556007 0.76 KMT2A (0.39) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL5555512 0.76 MAPT (0.42) ALDH1A1MAPTKDM4EGAA
SCHEMBL5556272 0.76 ALDH1A1 (0.40) ALDH1A1MAPTLMNANPSR1TDP1
SCHEMBL5561621 0.73 MAPT (0.40) ALDH1A1MAPTLMNATDP1KDM4E
SCHEMBL5555802 0.72 HCRTR1 (0.38) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL5556335 0.71 MDM2 (0.39) ALDH1A1NPSR1TDP1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-B1 2,3,4,5-TETRAHYDROBENZO¬F|¬1,4|OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2007-04-25 EP claimed